PubMed 35724659

PubMed ID: 35724659

View on PubMed
Rational domestication of a plant-based recombinant expression system expands its biosynthetic range.
Authors: Jackson Mark A, Chan Lai Yue, Harding Maxim D, Craik David J, Gilding Edward K
Journal: Journal of experimental botany (J Exp Bot), Vol.73(18), 2022‑Oct‑18

DOI: 10.5061/dryad.k6djh9w88 PMCID: PMC3718848

Abstract
Plant molecular farming aims to provide a green, flexible, and rapid alternative to conventional recombinant expression systems, capable of producing complex biologics such as enzymes, vaccines, and antibodies. Historically, the recombinant expression of therapeutic peptides in plants has proven difficult, largely due to their small size and instability. However, some plant species harbour the capacity for peptide backbone cyclization, a feature inherent in stable therapeutic peptides. One obstacle to realizing the potential of plant-based therapeutic peptide production is the proteolysis of the precursor before it is matured into its final stabilized form. Here we demonstrate the rational domestication of Nicotiana benthamiana within two generations to endow this plant molecular farming host with an expanded repertoire of peptide sequence space. The in planta production of molecules including an insecticidal peptide, a prostate cancer therapeutic lead, and an orally active analgesic is demonstrated.
Publication Types
Journal Article Research Support, Non-U.S. Gov't
Keywords
Asparaginyl endopeptidase (AEP) CRISPR/Cas9 cyclotide gene editing insecticide peptide plant molecular farming protease recombinant therapeutic
Grant Support
Related Articles